Related Experiment Video
Updated: Jun 17, 2026

Utilizing an Orally Dissolving Strip for Pharmacological and Toxicological Studies: A Simple and Humane Alternative to Oral Gavage for Animals
Published on: March 23, 2016
14-day repeat-dose oral toxicity evaluation of oxazyme in rats and dogs
Aaron B Cowley1, Duane W Poage, Robin R Dean
1Captozyme LLC, Gainesville, FL, USA.
Abstract:
Oxazyme (OC4) is an orally administered formulation that has as an active component a recombinant mutant form of Bacillus subtilis oxalate decarboxylase (OxDC) enzyme C383S, designed to degrade dietary oxalate in the stomach. Fourteen-day repeat-dose studies were conducted in rats and dogs to evaluate toxicity and determine a no observed adverse effect level (NOAEL). Animals were administered OC4 by oral gavage twice daily for 14 consecutive days. Reversibility, progression, and delayed appearance of any observed changes were evaluated in a subset of animals that underwent a recovery of 7 days following 14 days of control or test-article. There were no test-article-related adverse effects or deaths in either species. Results indicate that the NOAEL under the conditions used in the studies was 720.8 mg/kg/d in rats and 187.2 mg/kg/d in dogs, the high dose tested in each species.
Related Concept Videos
Toxicity Testing in Animals
Dosage Regimen: Multiple Oral Dosage
Bioavailability Study Design: Single Versus Multiple Dose Studies
Drug Toxicity: Dose-Dependent Reactions
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Dosage Regimen: Fixed Dose
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
